1. Home
  2. SPOK vs XOMA Comparison

SPOK vs XOMA Comparison

Compare SPOK & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

N/A

Current Price

$11.83

Market Cap

267.8M

ML Signal

N/A

Logo XOMA Corporation

XOMA

XOMA Corporation

N/A

Current Price

$26.42

Market Cap

308.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SPOK
XOMA
Founded
2004
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
267.8M
308.6M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
SPOK
XOMA
Price
$11.83
$26.42
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$14.00
$60.60
AVG Volume (30 Days)
136.3K
235.2K
Earning Date
05-28-2026
01-01-0001
Dividend Yield
9.08%
N/A
EPS Growth
N/A
N/A
EPS
0.62
N/A
Revenue
$137,653,000.00
N/A
Revenue This Year
$5.28
$77.29
Revenue Next Year
N/A
$29.30
P/E Ratio
$22.21
$29.64
Revenue Growth
N/A
N/A
52 Week Low
$12.26
$18.40
52 Week High
$19.31
$39.92

Technical Indicators

Market Signals
Indicator
SPOK
XOMA
Relative Strength Index (RSI) 27.29 53.59
Support Level N/A $23.71
Resistance Level $13.68 $27.73
Average True Range (ATR) 0.39 1.28
MACD -0.09 0.38
Stochastic Oscillator 6.00 79.08

Price Performance

Historical Comparison
SPOK
XOMA

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: